Dealspan makes strategic investment in FutureMeds
Updated: Sep 20, 2021
FutureMeds has completed a refinancing underpinned with investment from dealspan, a UK-based independent boutique investment firm.
Currently operating 6 sites in Poland, FutureMeds is growing towards being Europe’s leading independent Site Management Organization.
“We are delighted to have dealspan as partners. The successful funding round and dealspan’s backing will support investment across Europe with the FutureMeds Dedicated Research Site Network growing to 12 sites by the end of 2021. We have already found their advice invaluable, and they quickly assimilated our business opportunity and we are confident they will be key partners into helping us achieve our strategic ambitions.”
- Dr Radoslaw Janiak, CEO of FutureMeds.
Dealspan’s team with over 25 years of experience will continue to provide strategic advice with Ged Gould joining the Board to help turbocharge the growth plans of FutureMeds.
As per FutureMeds’ roadmap, Dedicated Research Sites will be opened in Bulgaria, the United Kingdom and Ukraine in the coming months.
Ged Gould, Founding Director of Dealspan commented “It is a pleasure to partner with the team at FutureMeds again. The market opportunity is strong for FutureMeds and we look forward to advising the team on their journey.”